NCT05013164View on ClinicalTrials.gov

Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Folinic Acid

Folinic Acid was given at the dose of 2mg/kg per day in two divide doses( maximum 50 mg per day) given for 12 weeks

Trial Locations (1)

60650

Children's Hospital and Institute of Child Health, Multan

All Listed Sponsors
lead

Nishtar Medical University

OTHER

NCT05013164 - Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter